UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011572
Receipt number R000013534
Scientific Title Randomized clinical trial on the efficacy and safety of perioperative management using ERAS protocol in gastric cancer
Date of disclosure of the study information 2013/08/24
Last modified on 2017/04/17 21:26:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized clinical trial on the efficacy and safety of perioperative management using ERAS protocol in gastric cancer

Acronym

Randomized clinical trial on perioperative management using ERAS(Enhanced recovery after surgery) protocol in gastric cancer

Scientific Title

Randomized clinical trial on the efficacy and safety of perioperative management using ERAS protocol in gastric cancer

Scientific Title:Acronym

Randomized clinical trial on perioperative management using ERAS(Enhanced recovery after surgery) protocol in gastric cancer

Region

Japan


Condition

Condition

Gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of perioperative management using ERAS protocol in gastrectomy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Postoperative lengths of stay

Key secondary outcomes

Postoperative complication rate
Readmission rate
Mortality rate
Weight loss rate


Base

Study type


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Shortened fasting period
Early oral intake
Omission of bowel preparation
Oral prophylactic analgesic

Interventions/Control_2

Conventional fasting period
Conventional oral intake
bowel preparation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients with radical surgery is scheduled.
2)ASA(American Society of Anesthesiology)class 1-3.
3)T factor T1a-T4a.
4)Weight loss rate the month prior to surgery is within 10%.
5)Written informed consent must be obtained from patients.

Key exclusion criteria

1)Patients with severe complications.
2)Requiring resection the other organs except the gallbladder.
3)Patients with infection in progress.
4)Emergency surgery.
5)Patients with uncontrolled diabetes.
6)Patients enrollment to the study is determined to be inappropriate.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhisa Uchiyama

Organization

Osaka medical college

Division name

General and Gastroenterological Surgery

Zip code


Address

2-7 Daigaku-machi, Takatsuki city Osaka, Japan

TEL

072-684-6263

Email

uchi@poh.osaka-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ryo Tanaka

Organization

Osaka medical college

Division name

General and Gastroenterological Surgery

Zip code


Address

2-7 Daigaku-machi, Takatsuki city Osaka, Japan

TEL

072-684-6263

Homepage URL


Email

sur148@poh.osaka-med.ac.jp


Sponsor or person

Institute

Osaka medical college,
General and Gastroenterological Surgery

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 24 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 09 Month 01 Day

Last follow-up date

2016 Year 06 Month 30 Day

Date of closure to data entry

2016 Year 06 Month 30 Day

Date trial data considered complete

2016 Year 06 Month 30 Day

Date analysis concluded

2016 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 08 Month 24 Day

Last modified on

2017 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013534


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name